18h
Medpage Today on MSNSemaglutide Tied to Small Risk of Potentially Blinding Eye ConditionThe use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in ...
Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol ...
Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...
Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...
Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
A breakthrough study reveals that semaglutide, found in Ozempic and Wegovy, could help reduce alcohol cravings and heavy ...
6d
ZME Science on MSNOzempic Users Are Drinking Less Alcohol Without Even TryingIn a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...
Hosted on MSN1d
The Unexpected Gut Problems Semaglutide Can CauseResearch is still evolving to identify all the ways semaglutide can affect your overall health. Even so, it probably makes ...
Semaglutide prescription initiation predictors included female sex and use of antidepressants among patients with obesity without diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results